Analyses of butyrophenones and their analogues in whole blood by high-performance liquid chromatography-electrospray tandem mass spectrometry

被引:14
作者
Seno, H
Hattori, H
Ishii, A
Kumazawa, T
Watanabe-Suzuki, K
Suzuki, O
机构
[1] Hamamatsu Univ Sch Med, Dept Legal Med, Hamamatsu, Shizuoka 4313192, Japan
[2] Aichi Med Univ, Dept Legal Med, Nagakute, Aichi 4801195, Japan
[3] Nagoya Univ, Postgrad Med Sch, Dept Legal Med & Bioeth, Showa Ku, Nagoya, Aichi 4668550, Japan
[4] Showa Univ, Sch Med, Dept Legal Med, Shinagawa Ku, Tokyo 1428555, Japan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2000年 / 746卷 / 01期
关键词
butyrophenones;
D O I
10.1016/S0378-4347(00)00124-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Five butyrophenones and two analogues contained in human whole blood have been analyzed by high-performance Liquid chromatography (HPLC)-electrospray (ES)-tandem mass spectrometry (MS). All compounds gave the base peaks due to [M+1](+) by HPLC-ES-single MS. The product ions formed from each quasi-molecular ion by HPLC-ES-tandem MS showed the base peaks at m/z 165 for four compounds. The mass chromatography of HPLC-ES-tandem MS showed much higher sensitivity than that of HPLC-ES-single MS for all drugs spiked to whole blood. Therefore, regression equations, detection limits, recovery rates and precision were studied for haloperidol, bromperidol and floropipamide spiked to human whole blood by means of mass chromatography of HPLC-ES-tandem MS. The three compounds showed good linearity in the range of 0.2-0.8 ng/ml with a detection limit of about 0.1 ng/ml. Recoveries of the three compounds spiked to whole blood (0.2 and 0.8 ng added to 1 mi whole blood) were 23.6-81.2%; the coefficients of intra- and inter-day variations were 8.4-10.4 and 14.5-17.5%, respectively. The three compounds in whole blood could be actually determined 3 and 6 h after oral administration of 1 mg each of haloperidol and bromperidol, and 10 mg of floropipamide in a volunteer. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 15 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF HALOPERIDOL AND HYDROXYHALOPERIDOL IN PLASMA AFTER SOLID-PHASE EXTRACTION [J].
CAHARD, C ;
ROP, PP ;
CONQUY, T ;
VIALA, A .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 532 (01) :193-202
[2]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETECTION AND QUANTITATION OF HALOPERIDOL AND 7 OF ITS METABOLITES IN MICROSOMAL PREPARATIONS [J].
FANG, J ;
GORROD, JW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 614 (02) :267-273
[3]   POSITIVE-ION AND NEGATIVE-ION MASS-SPECTROMETRY OF BUTYROPHENONES [J].
HATTORI, H ;
SUZUKI, O ;
BRANDENBERGER, H .
JOURNAL OF CHROMATOGRAPHY, 1986, 382 :135-145
[4]   SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR THERAPEUTIC MONITORING OF HALOPERIDOL LEVELS [J].
HOFFMAN, DW ;
EDKINS, RD .
THERAPEUTIC DRUG MONITORING, 1994, 16 (05) :504-508
[5]   Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography mass spectrometry with electrospray ionization [J].
Hoja, H ;
Marquet, P ;
Verneuil, B ;
Lotfi, H ;
Dupuy, JL ;
Penicaut, B ;
Lachatre, G .
JOURNAL OF CHROMATOGRAPHY B, 1997, 688 (02) :275-280
[6]  
LUHMANN I, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1069
[7]   Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol [J].
Pan, LP ;
Rosseel, MT ;
Belpaire, FM .
THERAPEUTIC DRUG MONITORING, 1998, 20 (02) :224-230
[8]  
POMMERY J, 1990, ANN BIOL CLIN-PARIS, V48, P455
[9]  
SENO H, 1989, Z RECHTSMED, V102, P127
[10]   Determination of timiperone in rat plasma by high-performance liquid chromatography with electrochemical detection [J].
Takayasu, T ;
Kakubari, I ;
Fukamachi, A ;
Mafune, E ;
Takasugi, N ;
Takayama, K ;
Nagai, T .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 679 (1-2) :161-165